Page last updated: 2024-10-29

ketamine and Leukemia, Lymphoid

ketamine has been researched along with Leukemia, Lymphoid in 3 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forlini, J1
Morin, DM1
Treacy, S1
Bennett, JA1
Bullimore, JA1
Catton, DV1

Other Studies

3 other studies available for ketamine and Leukemia, Lymphoid

ArticleYear
Painless peds procedures.
    The American journal of nursing, 1987, Volume: 87, Issue:3

    Topics: Acute Disease; Anesthesia, General; Child; Child, Preschool; Female; Humans; Infant; Ketamine; Leuke

1987
The use of ketamine hydrochloride anaesthesia for radiotherapy in young children.
    British journal of anaesthesia, 1973, Volume: 45, Issue:2

    Topics: Anesthesia, General; Child, Preschool; Female; Hemangioma; Humans; Immobilization; Infant; Injection

1973
Intramuscular ketamine-repeated injections.
    Canadian Anaesthetists' Society journal, 1973, Volume: 20, Issue:2

    Topics: Anesthesia, General; Child, Preschool; Humans; Injections, Intramuscular; Ketamine; Leukemia, Lympho

1973